LONDON, ON, Feb. 27 /CNW/ - Class Action lawsuits were launched in
Ontario, British Columbia and Quebec against Janssen-Ortho Inc. regarding its
contraceptive skin patch EVRA(R) (a/k/a "ORTHO EVRA(R)"), beginning in July
2006. Evra was first approved for marketing and sale in Canada as a
contraceptive in 2002.
The Statement of Claim alleges that Janssen-Ortho Inc. failed to
adequately warn patients and physicians of EVRA(R)'s association with an
increased risk of developing blood clots, pulmonary emboli, strokes, heart
attacks and/or deep vein thrombosis, as compared to oral contraceptive
Janssen-Ortho Inc., without any admission of liability, has agreed to
settle certain claims on an individual basis. As a result of Janssen-Ortho
Inc.'s cooperation, the class action lawsuit in Ontario will be discontinued.
Michael Peerless, a partner at Siskinds, LLP, lawyers for the class,
commented that "Janssen-Ortho Inc. should be commended for taking proactive
steps at resolving individual claims and not dragging their heels or these
claimants through a long, drawn-out litigation process".
For further information:
For further information: concerning the discontinuance, or your
individual rights, please contact Michael Peerless at 1-800-461-6166, ext.
7866 of Siskinds, LLP, 680 Waterloo Street, London, ON, N6A 3V8. In Quebec,
please contact Claude Desmeules of Siskinds Desmeules, at (418) 694-2009